ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

‘Approval to Apply’ For Proton Facility Upgrade Denied

February 24, 1989

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009